254 related articles for article (PubMed ID: 7026137)
1. [Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
Baronchelli A; Agosta R; Verdecchia P; Bichisao E
Clin Ter; 1981 Apr; 97(1):63-9. PubMed ID: 7026137
[No Abstract] [Full Text] [Related]
2. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
[TBL] [Abstract][Full Text] [Related]
3. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
Karachalios GN
Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
Krönig B; Wendt G
Med Welt; 1983 Sep; 34(35):941-4. PubMed ID: 6355745
[No Abstract] [Full Text] [Related]
5. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
Gruppillo P; Tomasi AM; Masoni A; Finzi C
G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
[No Abstract] [Full Text] [Related]
6. [Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
Albanesi Filho FM; Benchimol AB
Arq Bras Cardiol; 1980 May; 34(5):409-14. PubMed ID: 7006573
[No Abstract] [Full Text] [Related]
7. [Experience in the ambulatory treatment of primary arterial hypertension with a fixed oxprenolol-chlorthalidone combination].
Zampaglione G; Ferrari O; Bianchi C; Bonifazi C; Coppetti S; Costanza G; Lanzarini L; Ricevuti A; Rinaldo R; Rizzi GM; Tavecchi L; Ziletti G; Distante S
G Clin Med; 1980 Oct; 61(10):776-88. PubMed ID: 7239053
[No Abstract] [Full Text] [Related]
8. Influence of the administration time on the antihypertensive and hypokalaemic effects of chlorthalidone in patients with primary hypertension.
Carpentiere G; Marino S; Castello F
Int J Clin Pharmacol Res; 1985; 5(2):109-12. PubMed ID: 3894256
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three different methods of monitoring unwanted effects during antihypertensive therapy.
Borghi C; Pallavini G; Comi D; Grillo G; Lombardo M; Mantero O; Minetti L; Selvini A; Suppa G
Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):324-8. PubMed ID: 6378807
[TBL] [Abstract][Full Text] [Related]
10. [Comparative trial of combined oxprenolol-chlorthalidone and a beta-blockader and diuretic separately in primary arterial hypertension].
Luna RL; Faerchtein I; de Vasconcelos EM; Arslanian L; de La Nuez SB; Pereira WQ; Puppin S; Campos JC; Roque AF; Kastansky I
Arq Bras Cardiol; 1979 Oct; 33(4):311-20. PubMed ID: 398212
[No Abstract] [Full Text] [Related]
11. [Treatment of hypertension with a combination of beta receptor blockers and diuretics (Trasitensin retard)].
Mertz DP
MMW Munch Med Wochenschr; 1979 Feb; 121(7):251-2. PubMed ID: 105287
[No Abstract] [Full Text] [Related]
12. [Comparative study of the hypotensive effect of a combination of oxprenolol-chlortalidone with single and fractionated administration].
Rubegni M; Provvedi D; Bandinelli C; Bellini PG; De Mauro G
Boll Soc Ital Cardiol; 1976; 21(10):1853-8. PubMed ID: 1031614
[No Abstract] [Full Text] [Related]
13. Atenolol and chlorthalidone administered alone and in combination for essential hypertension.
Boike SC; Durley Y; Cubberley RB
Clin Pharm; 1982; 1(5):449-53. PubMed ID: 6764166
[No Abstract] [Full Text] [Related]
14. [Long-term experiences with an antihypertensive combination].
Hilgert A; Horch G
Med Welt; 1982 Jul; 33(29-30):1067-70. PubMed ID: 6750310
[No Abstract] [Full Text] [Related]
15. [Hypotensive effect of delayed-action oxprenolol and chlorthalidone in combined form in patients with primary arterial hypertension].
Cybulska I; Sznajderman M
Pol Tyg Lek; 1984 Apr; 39(15):501-3. PubMed ID: 6384962
[No Abstract] [Full Text] [Related]
16. [Ergometric studies for supplementary evaluation of antihypertensive therapy].
Franz IW; Lohmann FW
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():325-7. PubMed ID: 347807
[No Abstract] [Full Text] [Related]
17. [An example of an acceptable combination in the treatment of arterial hypertension].
Menard J; Plouin PF; Gouin F; Corvol P; Milliez P
Sem Hop; 1978 Feb; 54(4):201-6. PubMed ID: 208167
[No Abstract] [Full Text] [Related]
18. Effects of chlorthalidone, oxprenolol, and their combination in hypertensive blacks: a randomized double-blind crossover study.
Obel AO
J Cardiovasc Pharmacol; 1989 Mar; 13(3):465-70. PubMed ID: 2471894
[TBL] [Abstract][Full Text] [Related]
19. Once daily combination therapy for hypertension.
Asbury MJ; Wells FO; Barker NP
Practitioner; 1980 Dec; 224(1350):1306-9. PubMed ID: 7012818
[No Abstract] [Full Text] [Related]
20. [Reduction of left ventricular hypertrophy and increased tolerance to exertion in hypertensive patients after antihypertensive therapy with slow-release oxprenolol and chlorthalidone].
Sau F; Seguro C; Alberti D; Cherchi A
Cardiologia; 1986 Sep; 31(9):701-8. PubMed ID: 2949838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
